This site uses cookies. You can read how we use them in our privacy policy.

pulmonary fibrosis

and infection

sign up to receive our news and updates

  • This form collects your name and email address so that we can keep you updated with news and information about Breathing Matters. Please check our Privacy Policy to see how we protect and manage your data.

Stories from July, 2011


  • Related articles
  • Categories
  • Archives

Grant Awarded for Study into the Role of Platelets in Pulmonary Fibrosis

I mentioned in a previous post that £10K raised at our successful UCLH Charity Bike Ride in June will fund a clinical study looking into the role of platelets in pulmonary fibrosis (PF).

We are extremely happy to tell you that Dr Joanna Porter and Dr Chris Scotton from the Centre for Respiratory Research (CRR) have been awarded a competitive grant of £38K by the Clinical Research and Development Committee at UCLH to investigate the role of inflammation in PF. In particularthis will allow important studies to look at the role of platelets and white blood cells in PF.  These findings may suggest new ways to treat PF by preventing platelet and white blood cell activation.  The money will be used to employ a scientist for this lab-based study, Dr Carine Rebeyrol, who is currently working on lung disease at INSERM in Paris, to join the CRR and to bring her expertise to combine with our own.

We will keep you updated.

Quiz Answers: Summer 2011 Newsletter

Where on Earth? 

In which cities would you find the following:

1. The Acropolis – Athens

2. The Forbidden City – Beijing

3. Alhambra Palace – Granada

4. Sugarloaf Mountain – Rio de Janeiro

5. The Blue Mosque – Istanbul

6. St Mark’s Square – Venice

New Pulmonary Fibrosis Research Study

IPF Lung with Hotspots

IPF Lung with Hotspots

Pulmonary fibrosis (PF) affects 10,000 new patients each year in the UK, but there is still no cure. We believe that platelets may play a role in the development of PF.  Platelets are the very small cells that circulate in the blood and stick together to form a blood clot if the blood vessel is damaged. Blood clots are important to prevent bleeding, but blood clots may also cut off the blood supply to essential areas like the heart (a heart attack) or brain (a stroke), which is bad.  

We know that patients with PF are more likely, than other people, to develop diseases in which platelets are too sticky, such as heart disease.  We also know that PF is common in patients with rheumatoid arthritis and systemic sclerosis (or scleroderma) that have sticky platelets.  This suggests that platelets may play a role in PF.  

We plan to study patients with PF to see if their platelets are more sticky and whether the platelets are getting stuck in their lungs.  If we do find platelets sticking in the lungs, this suggests that platelets may cause PF and may help us find new treatments for this disease. 

£10K from the UCLH Charity Bike Ride 2011 has been donated towards this research study.

If any UCLH patients are interested in taking part in this study, please contact Breathing Matters on

For more information on the study, please see the attached Patient Information Sheet